These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

796 related items for PubMed ID: 15731027

  • 1. Relationship between surface accessibility for PpmA, PsaA, and PspA and antibody-mediated immunity to systemic infection by Streptococcus pneumoniae.
    Gor DO, Ding X, Briles DE, Jacobs MR, Greenspan NS.
    Infect Immun; 2005 Mar; 73(3):1304-12. PubMed ID: 15731027
    [Abstract] [Full Text] [Related]

  • 2. Protective Immune Responses Elicited by Fusion Protein Containing PsaA and PspA Fragments.
    Lu J, Sun T, Wang D, Dong Y, Xu M, Hou H, Kong FT, Liang C, Gu T, Chen P, Sun S, Lv X, Jiang C, Kong W, Wu Y.
    Immunol Invest; 2015 Mar; 44(5):482-96. PubMed ID: 26107747
    [Abstract] [Full Text] [Related]

  • 3. Identification of the targets of cross-reactive antibodies induced by Streptococcus pneumoniae colonization.
    Roche AM, Weiser JN.
    Infect Immun; 2010 May; 78(5):2231-9. PubMed ID: 20231407
    [Abstract] [Full Text] [Related]

  • 4. Comparison of four adjuvants revealed the strongest protection against lethal pneumococcal challenge following immunization with PsaA-PspA fusion protein and AS02 as adjuvant.
    Chen X, Li B, Yu J, Zhang Y, Mo Z, Gu T, Kong W, Zhang Y, Wu Y.
    Med Microbiol Immunol; 2019 Apr; 208(2):215-226. PubMed ID: 30707297
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Immunogenic protein contaminants in pneumococcal vaccines.
    Yu J, Briles DE, Englund JA, Hollingshead SK, Glezen WP, Nahm MH.
    J Infect Dis; 2003 Mar 15; 187(6):1019-23. PubMed ID: 12660950
    [Abstract] [Full Text] [Related]

  • 7. Enhanced immunogenicity of pneumococcal surface adhesin A by genetic fusion to cytokines and evaluation of protective immunity in mice.
    Gor DO, Ding X, Li Q, Schreiber JR, Dubinsky M, Greenspan NS.
    Infect Immun; 2002 Oct 15; 70(10):5589-95. PubMed ID: 12228286
    [Abstract] [Full Text] [Related]

  • 8. A pneumococcal vaccine combination with two proteins containing PspA families 1 and 2 can potentially protect against a wide range of Streptococcus pneumoniae strains.
    Yu J, Chen X, Li B, Gu T, Meng X, Kong W, Wu Y.
    Immunol Res; 2018 Aug 15; 66(4):528-536. PubMed ID: 30128745
    [Abstract] [Full Text] [Related]

  • 9. [Immunoprotective effect of combined pneumococcal endopeptidase O and pneumococcal surface adhesin A vaccines against Streptococcus pneumoniae infection].
    Zhang J, Cui YL, Jiang YM.
    Zhongguo Dang Dai Er Ke Za Zhi; 2017 May 15; 19(5):583-589. PubMed ID: 28506354
    [Abstract] [Full Text] [Related]

  • 10. Intranasal immunization with recombinant PspA fused with a flagellin enhances cross-protective immunity against Streptococcus pneumoniae infection in mice.
    Nguyen CT, Kim SY, Kim MS, Lee SE, Rhee JH.
    Vaccine; 2011 Aug 05; 29(34):5731-9. PubMed ID: 21696869
    [Abstract] [Full Text] [Related]

  • 11. Immunization with components of two iron uptake ABC transporters protects mice against systemic Streptococcus pneumoniae infection.
    Brown JS, Ogunniyi AD, Woodrow MC, Holden DW, Paton JC.
    Infect Immun; 2001 Nov 05; 69(11):6702-6. PubMed ID: 11598041
    [Abstract] [Full Text] [Related]

  • 12. Enhanced protective immunity against pneumococcal infection with PspA DNA and protein.
    Moore QC, Bosarge JR, Quin LR, McDaniel LS.
    Vaccine; 2006 Jul 17; 24(29-30):5755-61. PubMed ID: 16759765
    [Abstract] [Full Text] [Related]

  • 13. A modified surface killing assay (MSKA) as a functional in vitro assay for identifying protective antibodies against pneumococcal surface protein A (PspA).
    Genschmer KR, Accavitti-Loper MA, Briles DE.
    Vaccine; 2013 Dec 17; 32(1):39-47. PubMed ID: 24211169
    [Abstract] [Full Text] [Related]

  • 14. Antibodies to the pneumococcal surface protein A, PspA, can be produced in splenectomized and can protect splenectomized mice from infection with Streptococcus pneumoniae.
    Coats MT, Benjamin WH, Hollingshead SK, Briles DE.
    Vaccine; 2005 Jul 21; 23(33):4257-62. PubMed ID: 16005736
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Conserved surface accessible nucleoside ABC transporter component SP0845 is essential for pneumococcal virulence and confers protection in vivo.
    Saxena S, Khan N, Dehinwal R, Kumar A, Sehgal D.
    PLoS One; 2015 Jul 21; 10(2):e0118154. PubMed ID: 25689507
    [Abstract] [Full Text] [Related]

  • 17. Genetic immunization with the region encoding the alpha-helical domain of PspA elicits protective immunity against Streptococcus pneumoniae.
    Bosarge JR, Watt JM, McDaniel DO, Swiatlo E, McDaniel LS.
    Infect Immun; 2001 Sep 21; 69(9):5456-63. PubMed ID: 11500417
    [Abstract] [Full Text] [Related]

  • 18. Protective humoral response against pneumococcal infection in mice elicited by recombinant bacille Calmette-Guérin vaccines expressing pneumococcal surface protein A.
    Langermann S, Palaszynski SR, Burlein JE, Koenig S, Hanson MS, Briles DE, Stover CK.
    J Exp Med; 1994 Dec 01; 180(6):2277-86. PubMed ID: 7964500
    [Abstract] [Full Text] [Related]

  • 19. Preparation and immunogenicity of capsular polysaccharide-surface adhesin A (PsaA) conjugate of Streptococcuspneumoniae.
    Lin H, Lin Z, Meng C, Huang J, Guo Y.
    Immunobiology; 2010 Jul 01; 215(7):545-50. PubMed ID: 19880214
    [Abstract] [Full Text] [Related]

  • 20. Development of 5-valent conjugate pneumococcal protein A - Capsular polysaccharide pneumococcal vaccine against invasive pneumococcal disease.
    Meng C, Lin H, Huang J, Wang H, Cai Q, Fang L, Guo Y.
    Microb Pathog; 2009 Sep 01; 47(3):151-6. PubMed ID: 19467319
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 40.